GoAI
Get started
JTEC Corporation logo

JTEC Corporation

3446.T

JPXHealthcareMedical - Instruments & Supplies

Open in GoAI

Latest quote

¥1,599

−¥11.00 · -0.68%

Aug 24, 3:30 PM JST

3446.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

JTEC Corporation specializes in the full spectrum of automation systems, from their initial development and design to manufacturing and ultimate sale. The company's activities are divided into two core segments: Optical Business and the Development of Automatic Systems for Life-Science Devices. The Optical Business unit is responsible for producing and supplying highly precise X-ray mirrors, which are utilized across various industries such as pharmaceutical research, electronics, materials science, food production, and cosmetics. Meanwhile, the Automated Systems for Life-Science Devices division engineers and produces automated equipment and integrated systems. These solutions serve a broad range of sectors, including pharmaceuticals, semiconductors, chemistry, printing, color recognition, image processing, and software development. Founded by Takashi Tsumura on December 21, 1993, JTEC Corporation's corporate headquarters are located in Ibaraki, Japan.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
Headquarters
JP
CEO
Takashi Tsumura
Listed since
Mar 1, 2018
Employees
76

Market position

Day range

Current ¥1,599

52-week range

Current ¥1,599

Open
¥1,611
Previous close
¥1,610
Volume
16K
0.33× average
Average volume
48.47K
Average daily volume
Market cap
9.44B JPY
Beta
1.27
Market reference 1
50-day average
¥1,631.56
-2.00% below average
200-day average
¥1,663.4
-3.87% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
10.82B JPY
P/E (TTM)
160.87×
P/B (TTM)
3.31×
P/S (TTM)
4.83×
EV / EBITDA
45.01×
Earnings yield
0.54%
Free cash flow yield
-0.45%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
63.47%
Operating margin
3.73%
Net margin
3.00%
Return on equity
2.06%
Return on assets
1.63%
Return on invested capital
1.52%

Financial health

Debt / equity
0.15×
Current ratio
4.29×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends70%43%15%-13%Gross margin, FY2021: 60.81%Gross margin, FY2022: 61.04%Gross margin, FY2023: 62.32%Gross margin, FY2024: 61.22%Gross margin, FY2025: 63.47%Operating margin, FY2021: -6.19%Operating margin, FY2022: 16.07%Operating margin, FY2023: 14.22%Operating margin, FY2024: 5.91%Operating margin, FY2025: 3.73%Net margin, FY2021: -2.79%Net margin, FY2022: 12.48%Net margin, FY2023: 9.93%Net margin, FY2024: 3.13%Net margin, FY2025: 3.00%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 60.81%. Gross margin FY2022 61.04%. Gross margin FY2023 62.32%. Gross margin FY2024 61.22%. Gross margin FY2025 63.47%. Operating margin FY2021 -6.19%. Operating margin FY2022 16.07%. Operating margin FY2023 14.22%. Operating margin FY2024 5.91%. Operating margin FY2025 3.73%. Net margin FY2021 -2.79%. Net margin FY2022 12.48%. Net margin FY2023 9.93%. Net margin FY2024 3.13%. Net margin FY2025 3.00%.

Income trends

Revenue

1.96B JPY+1.58%

Operating income

72.88M JPY-35.97%

Net income

58.69M JPY-2.75%
Income trends across reported periods2.22B JPY1.39B JPY553.25M JPY−279.38M JPYRevenue, FY2021: 1.15B JPYRevenue, FY2022: 1.91B JPYRevenue, FY2023: 2.01B JPYRevenue, FY2024: 1.93B JPYRevenue, FY2025: 1.96B JPYOperating income, FY2021: −71.22M JPYOperating income, FY2022: 306.67M JPYOperating income, FY2023: 285.84M JPYOperating income, FY2024: 113.82M JPYOperating income, FY2025: 72.88M JPYNet income, FY2021: −32.13M JPYNet income, FY2022: 238.19M JPYNet income, FY2023: 199.59M JPYNet income, FY2024: 60.35M JPYNet income, FY2025: 58.69M JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.15B JPY. Revenue FY2022 1.91B JPY. Revenue FY2023 2.01B JPY. Revenue FY2024 1.93B JPY. Revenue FY2025 1.96B JPY. Operating income FY2021 −71.22M JPY. Operating income FY2022 306.67M JPY. Operating income FY2023 285.84M JPY. Operating income FY2024 113.82M JPY. Operating income FY2025 72.88M JPY. Net income FY2021 −32.13M JPY. Net income FY2022 238.19M JPY. Net income FY2023 199.59M JPY. Net income FY2024 60.35M JPY. Net income FY2025 58.69M JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue1.96B JPY1.93B JPY2.01B JPY1.91B JPY1.15B JPY
Cost of goods sold714.55M JPY746.82M JPY757.59M JPY743.51M JPY451.07M JPY
Gross profit1.24B JPY1.18B JPY1.25B JPY1.16B JPY699.91M JPY
Research and development—282.57M JPY290.24M JPY263.01M JPY263.4M JPY
Selling, general, and administrative1.17B JPY782.38M JPY676.68M JPY595.19M JPY507.73M JPY
Operating expenses1.17B JPY1.06B JPY966.92M JPY858.2M JPY771.13M JPY
Interest income1.27M JPY402K JPY6K JPY6K JPY5K JPY
Interest expense5.19M JPY4.75M JPY3.28M JPY3.92M JPY3.9M JPY
Depreciation and amortization167.48M JPY158.74M JPY149.15M JPY145.15M JPY131.59M JPY
Operating income72.88M JPY113.82M JPY285.84M JPY306.67M JPY−71.22M JPY
Net income58.69M JPY60.35M JPY199.59M JPY238.19M JPY−32.13M JPY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
39.9

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates48.3423.7-0.94-25.58Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 12, 2024: actual -17.96, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 12, 2025: actual -10.68, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 12, 2025: actual -4.35, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 13, 2025: actual 43.24, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 13, 2025: actual -20.48, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 13, 2026: actual -2.97, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 14, 2026: actual -6.5, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 10, 2026: actual 39.9, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly Revenue actual values compared with estimates1.02B743.12M470.16M197.2MQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 12, 2024: actual 232M JPY, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 12, 2025: actual 332M JPY, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 12, 2025: actual 403M JPY, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 13, 2025: actual 958M JPY, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 13, 2025: actual 232M JPY, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 13, 2026: actual 414M JPY, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 14, 2026: actual 394M JPY, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 10, 2026: actual 915M JPY, estimate —, surprise —, Comparison unavailable.

3446.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,987

-0.34%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,797

+0.57%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,895

0.00%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,210

+0.12%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,858

+0.86%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,406.5

+0.82%

Continue in GoAI

Research 3446.T

research.disclaimer